Barry I. Freedman, MD, BRCU Faculty
Barry I. Freedman, MD, is John H. Felts, III Professor of Medicine and Chief, Section on Nephrology at the Wake Forest University School of Medicine. He also serves as Chief Medical Officer for Health Systems Management, Inc. His research focuses on identifying genes underlying complex kidney and cardiovascular disease, diabetes mellitus, and population-based disparities in risk of kidney diseases and atherosclerosis.
His work on familial clustering of ESKD in African Americans paved the way for the identification of major nephropathy risk variants. His team now works on clinical, and translational aspects of apolipoprotein L1 gene (APOL1)-associated kidney disease.
Dr. Freedman chaired the NIDDK Family Investigation in Nephropathy and Diabetes (FIND) Consortium and serves as PI on the NIDDK APOLLO Consortium (APOL1 Long-Term Kidney Transplant Outcomes) Coordinating Center and US Lead Physician on the AstraZeneca APPRECIATE Trial in APOL1-Mediated Kidney Disease. He has been the Principal Investigator on multiple NIH R01 and U01 applications and published more than 640 peer-reviewed manuscripts and editorials.